Antiviral Research Publishes Study on Benefits of Tychan’s Antibody Platform
17 Jun 2021 //
BUSINESSWIRE
Tychan to Start COVID-19 Phase 3 Clinical Trial For Novel Monoclonal TY027
11 Dec 2020 //
BUSINESSWIRE
17 Jun 2021 //
BUSINESSWIRE
11 Dec 2020 //
BUSINESSWIRE